Researchers concluded, “The evidence is sufficient to establish a potentially beneficial association between recreational marijuana legislation and prescription opioid patterns.”
The agency had previously opined that regulating hemp-derived CBD products as dietary supplements could potentially discourage the use and development of CBD prescription drugs.
“Our research found CBC to enhance the cytotoxic effect of CBD, establishing additional support for the phenomenon of the entourage effect,” investigators concluded.
Regulators are hopeful that the commission’s actions may clear the way for the opening of state-licensed dispensaries by this spring.
Investigators concluded, “Cannabis use does not appear to be related to lung function even after years of use.”
“People may be obtaining codeine from pharmacies for misuse; recreational cannabis laws reduce this illicit demand.”
“Subgroups with past-year cannabis use that displayed significant declines in DUIC include males, [those] ages 18–25, … and those living in a state with a medical cannabis law.”
The proposed rules are now subject to a public comment period, which runs until March 18, 2023.